Clinical Trials Browser

Phase 1/2 × Cholangiocarcinoma × lenvatinib × Clear all

NCT03781934 2025-07-01

A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Cholangiocarcinoma